Papers
3
Total Citations
25
H-Index
3
About
Weibin Wang is a leading figure in pancreatic surgery, with a primary focus on advancing robotic-assisted techniques and optimizing healthcare economics. His major contributions center on establishing the safety, feasibility, and cost-effectiveness of robotic distal pancreatectomy (RDP). In a landmark study of 301 cases, Wang mapped the learning curve for RDP, demonstrating that both operation time and complication rates improve significantly with experience, thereby validating its routine use in high-volume centers. His work has garnered over 25 citations, reflecting its influence on surgical practice. Notably, Wang has also pioneered health policy research, analyzing Diagnosis-Related Group (DRG) payment systems for major pancreatic surgery. His findings reveal cost heterogeneity within existing DRG classifications and propose refinements to improve reimbursement accuracy. Furthermore, his cost analysis of robotic pancreatic surgery challenges assumptions about expense, showing that robotic approaches actually reduce medical consumable consumption. These insights are reshaping surgical decision-making and healthcare resource allocation in China. Wang’s dual expertise in technical surgical innovation and health economics makes him a uniquely impactful researcher, bridging the gap between clinical excellence and sustainable healthcare delivery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3